Ben Kentish 10pm - 1am
Twitter adopts ‘poison pill’ defence in Musk takeover bid
15 April 2022, 19:34
Twitter revealed in a securities filing on Thursday that Elon Musk offered to buy the company outright for more than 43 billion dollars.
Twitter said on Friday that its board of directors has unanimously adopted a “poison pill” defence in response to Tesla CEO Elon Musk’s proposal to buy the company and take it private.
The move would allow existing Twitter shareholders to buy additional shares at a discount, thereby diluting Mr Musk’s stake in the company and making it harder for him to corral a majority of shareholder votes in favour of the acquisition.
Twitter’s plan would take effect if Mr Musk’s roughly 9% stake grows to 15% or more.
Twitter said the poison pill would enable its investors to “realise the full value of their investment” by reducing the likelihood that any one person can gain control of the company without either paying shareholders a premium or giving the board more time to evaluate their offer.
Such defences, formally called shareholder rights plans, are used to prevent the takeover of a corporation by making any acquisition prohibitively expensive for the bidder.
Even if it discourages his takeover attempt, Mr Musk could still take over the company by waging a “proxy fight” in which shareholders vote to retain or dismiss the company’s current directors.
Twitter said the plan does not prevent the board from engaging with parties or accepting an acquisition proposal if it is in the company’s best interests.
“They’re gearing up for a battle here with Musk,” said Daniel Ives, an analyst for Wedbush Securities. “They also have to give themselves time to try to find another potential buyer.”
Twitter revealed in a securities filing on Thursday that Mr Musk offered to buy the company outright for more than 43 billion dollars, saying the social media platform “needs to be transformed as a private company” in order to build trust with its users.
“I believe free speech is a societal imperative for a functioning democracy,” Mr Musk said in the filing. “I now realise the company will neither thrive nor serve this societal imperative in its current form.”
Later on Thursday, during an onstage interview at a TED event, he went even broader: “Having a public platform that is maximally trusted and broadly inclusive is extremely important to the future of civilisation.”
Mr Musk revealed in regulatory filings over recent weeks that he had been buying Twitter shares in almost daily batches starting January 31, ending up with a stake of about 9%. Only Vanguard Group controls more Twitter shares.
A lawsuit filed on Tuesday in New York federal court alleged that Mr Musk illegally delayed disclosing his stake in the social media company so he could buy more shares at lower prices.
After Mr Musk announced his stake, Twitter quickly offered him a seat on its board on the condition that he would limit his purchases to no more than 14.9% of the company’s outstanding stock. But the company said five days later that Mr Musk had declined.
Mr Ives said Twitter’s poison pill path is a predictable defensive manoeuvre but could be seen as a “sign of weakness” on Wall Street.